For example, bioanalysis can potentially contribute to the development of effective vaccines and drugs to treat diseases and help clinical researchers diagnose and treat people. 2 Due to its ...
The microfluidics market presents significant opportunities in laboratory-on-a-chip research, miniaturized diagnostics, pharmaceutical R&D, and personalized medicine. Growth drivers include ...
Microfluidics is an upcoming technology that has been used in many areas of chemical and biological research. One valuable application of this technique is in studying protein-protein interactions in ...
Microfluidics is the general term for the manipulation of nanoliter volumes of fluids through micro-channels. The field has led to the development of microfluidic devices or chips which are commonly ...
At the rack level, AI training clusters are now so dense that the thermal ceiling, not compute power, is what limits performance. This means that anyone relying on the traditional cold plate ...
Microfluidics and learning-on-a-chip research -- involving the manipulation of small amounts of fluids to run miniaturized experiments -- are a prolific research field. But there aren't yet many ...
The infection of human immunology viruses (HIV) occurs by integrating its genome into infected cells to enter an inactive state of reversible latency that evades anti-retroviral therapy. The capacity ...
Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Microfluidics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's ...
Between now and then, it’ll close a hefty venture capital infusion from Casdin Capital and Viking Global Investors—and use that to begin redirecting its business focus—then appoint a new CEO and ...
Nanodroplets promise to reduce the equipment, cost and time constraints of high-throughput screening, if researchers can overcome long-standing hurdles. You have full access to this article via your ...
Bioprocessing technologies designed for volume products are not well suited to small batch personalized medicines, according to researchers who say firms making patient-specific medicines need better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results